Exchange: NASDAQ·Updated 04:03 AM EDT
ALNY logo

ALNYAlnylam Pharmaceuticals Inc

$310.07
$2.72
(0.87%)
Pre-Market
Prev Close $312.79
EarningsJul 30
Mkt Cap$43.19B
Vol139.00

About

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2,500

Frequently Asked Questions

What is Market Cap of Alnylam Pharmaceuticals Inc?
What is the 52-week high for Alnylam Pharmaceuticals Inc?
What is the 52-week low for Alnylam Pharmaceuticals Inc?
What is Alnylam Pharmaceuticals Inc stock price today?
What was Alnylam Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Alnylam Pharmaceuticals Inc?
What is the Price-to-Book ratio of Alnylam Pharmaceuticals Inc?
What is the 50-day moving average of Alnylam Pharmaceuticals Inc?
How many employees does Alnylam Pharmaceuticals Inc have?

Latest ALNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.